Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Biotech
  • Healthcare
  • Cleantech
  • Technology
  • Other

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • IP Venture Fund II
  • Top 10 Holdings
    by value
Medical Equipment & Supplies

University: Oxford

Company Stage: Private (post-seed)

Website: http://www.crysalin.com

Crysalin

Crysalin was founded to research, develop and license crysalin lattice technology – a new area of protein-based nanotechnology. The technology is founded upon patented research conducted since 2002 in the Oxford University Laboratory of Molecular Biophysics. Crysalin lattice design principles allow for tailored crystal formation in 1-, 2- and 3- dimensions with repeating units on scales of approximately 1-100nm.

As at 31 Dec 2013

IP Group holding

IP Venture Fund* holding

25.1%

11.1%

*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt

Related news

There is currently no news available.

More portfolio news